XHR7XGAReplacement of Left Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- Billable / Specific Code
XHR7XGA is a billable ICD-10-PCS procedure code for Replacement of Left Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Replacement involves putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | H | Skin, Subcutaneous Tissue, Fascia and Breast |
| 3 | Operation | R | Replacement |
| 4 | BodyPart | 7 | Skin, Left Lower Extremity |
| 5 | Approach | X | External |
| 6 | Device/Substance/Technology | G | Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy |
| 7 | Qualifier | A | New Technology Group 10 |
Code History
Similar Procedure Codes
Questions About XHR7XGA
Is XHR7XGA a billable code?
Yes. XHR7XGA is a complete seven-character ICD-10-PCS code, specific enough to report Replacement of Left Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XHR7XGA mean?
XHR7XGA breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character H is the Body System (Skin, Subcutaneous Tissue, Fascia and Breast); the 3rd character R is the Operation (Replacement); the 4th character 7 is the BodyPart (Skin, Left Lower Extremity); the 5th character X is the Approach (External); the 6th character G is the Device/Substance/Technology (Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy); the 7th character A is the Qualifier (New Technology Group 10).
